Recent studies point to a pathogenic role for granulocyte-macrophage colony-stimulating factor (GM-CSF) producing T cells in MS via enhanced myeloid cell recruitment and activation [25, 26], and GM-CSF producing CD4+ and CD8+ T cells have been identified in MS brain lesions [27]. Here, CD8A is linked to myeloid sarcoma.